RCT | Efficacy and safety of methylphenidate and behavioral parent training for children aged 3–5 years with ADHD.
9 Nov, 2022 | 12:09h | UTCEfficacy and safety of methylphenidate and behavioural parent training for children aged 3–5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial – The Lancet Child & Adolescent Health (link to abstract – $ for full-text)
Commentary on Twitter (thread – click for more)
Methylphenidate was effective in reducing #ADHD symptoms and improving functionality, and behavioural parent training was effective in improving functionality for preschool children with ADHD after 8 weeks of treatment.
New RCT by @gvpolanczyk & team: https://t.co/iDUhRMTno4
— The Lancet Child & Adolescent Health (@LancetChildAdol) October 26, 2022